Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Never miss an Options trading signal: Unusual Options Activity and Options Screeners with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Immunic Inc (IMUX)

Immunic Inc (IMUX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 68,989
  • Shares Outstanding, K 95,818
  • Annual Sales, $ 0 K
  • Annual Income, $ -100,510 K
  • EBIT $ -101 M
  • EBITDA $ -101 M
  • 60-Month Beta 1.48
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book N/A
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -0.70
  • Most Recent Earnings $-0.25 on 05/15/25
  • Next Earnings Date 08/14/25
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sector Medical
  • INDUSTRY GROUPING Medical - Biomedical

Options Overview Details

View History
  • Implied Volatility 496.19% ( -197.58%)
  • Historical Volatility 99.43%
  • IV Percentile 87%
  • IV Rank 59.51%
  • IV High 809.76% on 02/05/25
  • IV Low 35.34% on 08/22/24
  • Put/Call Vol Ratio 0.02
  • Today's Volume 62
  • Volume Avg (30-Day) 62
  • Put/Call OI Ratio 0.06
  • Today's Open Interest 4,436
  • Open Int (30-Day) 13,938

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 7 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/25
See More
  • Average Estimate -0.19
  • Number of Estimates 6
  • High Estimate -0.12
  • Low Estimate -0.25
  • Prior Year -0.21
  • Growth Rate Est. (year over year) +9.52%

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.5600 +26.43%
on 05/29/25
0.9500 -25.47%
on 05/27/25
-0.2096 (-22.84%)
since 05/23/25
3-Month
0.5600 +26.43%
on 05/29/25
1.3500 -47.56%
on 03/25/25
-0.4420 (-38.43%)
since 03/21/25
52-Week
0.5600 +26.43%
on 05/29/25
2.1100 -66.45%
on 09/19/24
-0.4020 (-36.22%)
since 06/21/24

Most Recent Stories

More News
Immunic: Q1 Earnings Snapshot

Immunic: Q1 Earnings Snapshot

IMUX : 0.7080 (-1.67%)
Immunic Stock Draws Investor Attention On $5.1M Registered Direct Offering: Retail’s On Wait-And-Watch Mode

Immunic intends to use the net proceeds from the proposed offering to fund its clinical trials and operations and for other general corporate purposes.

IMUX : 0.7080 (-1.67%)
VXF : 188.49 (+0.97%)
VTI : 296.25 (+0.96%)
Winter 2024 Investor Summit Virtual: Q4 Presentations Now Available for On-Demand Viewing

NEW YORK, NY / ACCESSWIRE / December 3, 2024 / Investor Summit Group, committed to advancing the MicroCap and SmallCap investment community, announces that the November 21, 2024 Winter Investor Summit...

IMRN : 1.8300 (-0.54%)
ULY : 4.50 (+12.22%)
IMUX : 0.7080 (-1.67%)
NMTC : 0.6623 (+0.35%)
SNGX : 1.6500 (-2.94%)
TMG.VN : 0.125 (-3.85%)
BLGO : 0.2100 (+2.29%)
FET : 19.21 (-2.09%)
ACFN : 17.5000 (-2.78%)
NRBO : 2.36 (+0.43%)
TGCB : 0.0500 (+0.20%)
SOTK : 3.75 (-1.32%)
Immunic: Q3 Earnings Snapshot

Immunic: Q3 Earnings Snapshot

IMUX : 0.7080 (-1.67%)
Immunic: Q2 Earnings Snapshot

Immunic: Q2 Earnings Snapshot

IMUX : 0.7080 (-1.67%)
Immunic Presents Data From Phase 2 CALDOSE-1 Trial of Vidofludimus Calcium in Ulcerative Colitis at the United European Gastroenterology Week 2023

/PRNewswire/ -- Immunic, Inc. (Nasdaq: IMUX), a biotechnology company developing a clinical pipeline of orally administered, small molecule therapies for...

IMUX : 0.7080 (-1.67%)
Immunic Presents Data From Phase 1b Clinical Trial of IMU-856 in Celiac Disease at the United European Gastroenterology Week 2023

/PRNewswire/ -- Immunic, Inc. (Nasdaq: IMUX), a biotechnology company developing a clinical pipeline of orally administered, small molecule therapies for...

IMUX : 0.7080 (-1.67%)
Immunic Presents Data From Phase 2 EMPhASIS Trial of Vidofludimus Calcium in Relapsing-Remitting Multiple Sclerosis at MSMilan2023: The 9th Joint ECTRIMS-ACTRIMS Meeting

/PRNewswire/ -- Immunic, Inc. (Nasdaq: IMUX), a biotechnology company developing a clinical pipeline of orally administered, small molecule therapies for...

IMUX : 0.7080 (-1.67%)
Stock Index Futures Climb on Dovish Fed Comments, PepsiCo Earnings on Tap

December S&P 500 futures (ESZ23) are up +0.20%, and December Nasdaq 100 E-Mini futures (NQZ23) are up +0.26% this morning as comments from Fed officials bolstered bets that the U.S. central bank may stand...

NOC : 499.67 (+0.40%)
JNPR : 36.30 (+0.75%)
IMUX : 0.7080 (-1.67%)
EXAS : 52.54 (-0.91%)
DDOG : 129.52 (+1.58%)
NQZ23 : 16,530.23s (-0.07%)
RIVN : 13.65 (+0.59%)
AAL : 10.90 (+2.64%)
DAL : 48.25 (+2.22%)
ELIS.FP : 23.940 (+1.53%)
LMT : 472.46 (+0.40%)
PD : 14.08 (+1.15%)
Immunic Reports Positive Interim Data from Phase 2 CALLIPER Trial of Vidofludimus Calcium in Progressive Multiple Sclerosis

– 24-Week Data from First Half of Patients Shows Improvements in Biomarker NfL, Consistent Throughout the Overall Progressive Multiple Sclerosis Population as...

IMUX : 0.7080 (-1.67%)

Business Summary

Immunic Inc. is a clinical-stage biopharmaceutical company. It is engaged in developing a pipeline of selective oral immunology therapies aimed at treating chronic inflammatory and autoimmune diseases including ulcerative colitis, Crohn's disease, relapsing-remitting multiple sclerosis and psoriasis....

See More

Key Turning Points

3rd Resistance Point 0.8245
2nd Resistance Point 0.7889
1st Resistance Point 0.7484
Last Price 0.7080
1st Support Level 0.6723
2nd Support Level 0.6367
3rd Support Level 0.5962

See More

52-Week High 2.1100
Fibonacci 61.8% 1.5179
Fibonacci 50% 1.3350
Fibonacci 38.2% 1.1521
Last Price 0.7080
52-Week Low 0.5600

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar